What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001166309
Total reported value
$150.1M
$150.1M
29 檔
59.4%
According to the latest 13F quarterly dataset, Bridger Management, LLC managed an equity portfolio of $150.1M at the end of Q3 2024, spanning 29 distinct U.S. exchange-listed positions.
Bridger Management, LLC executed strategic sector rebalancing during Q3 2024, establishing 6 new positions while fully exiting 5 holdings and trimming 2 positions.
In terms of portfolio concentration, the top 5 core holdings (including UBER, MS, VRTX) accounted for 59.4% of total reported equity market value during Q3 2024.
Top New Position Initiated
WYNN
市值: $9.6M
Top Position Liquidated / Trimmed
LLY
前期市值: $22.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | UBER | Uber Technologies Inc | Stock-Industrials | 11.33% | -0.47% | — | |
| 2 | MS | Morgan Stanley | Stock-Financials | 9.79% | +1.20% | — | |
| 3 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 9.55% | — | — | |
| 4 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 8.84% | -0.35% | — | |
| 5 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 5.09% | — | — | |
| 6 | PFE | Pfizer Inc | Stock-Healthcare | 5.07% | — | — | |
| 7 | BLCO | Bausch + Lomb CORP | Stock-Other | 4.89% | — | — | |
| 8 | WYNN | Wynn Resorts LTD | Stock-Consumer Disc | 4.81% | — | — | |
| 9 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 4.39% | +3.28% | NEW | |
| 10 | GDX | Vaneck Gold Miners ETF | ETF-Commodities | 3.86% | — | — | |
| 11 | MLCO | Melco Resorts & Entert-adr | Stock-Other | 3.83% | -0.48% | — | |
| 12 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 3.77% | — | — | |
| 13 | BBWI | Bath & Body Works Inc | Stock-Consumer Disc | 3.54% | — | — | |
| 14 | CZR | Caesars Entertainment Inc | Stock-Consumer Disc | 3.08% | — | — | |
| 15 | GERN | Geron CORP | Stock-Other | 3.04% | — | — | |
| 16 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 2.89% | — | — | |
| 17 | SWTXUSD | Springworks Therapeutics Inc | Stock-Other | 2.32% | — | — | |
| 18 | IBIT | Ishares Bitcoin Trust ETF | ETF-Crypto | 1.96% | -0.66% | — | |
| 19 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 1.15% | +0.25% | — | |
| 20 | QTRX | Quanterix CORP | Stock-Other | 1.00% | — | — | |
| 21 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 1.00% | — | — | |
| 22 | MSFT | Microsoft CORP | Stock-Tech | 0.91% | -0.50% | — | |
| 23 | CPRX | Catalyst Pharmaceuticals Inc | Stock-Healthcare | 0.90% | — | -50.87% | |
| 24 | SVRA | Savara Inc | Stock-Other | 0.80% | — | — | |
| 25 | TOST | Toast Inc-class A | Stock-Tech | 0.75% | -0.09% | — | |
| 26 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 0.68% | -0.25% | — | |
| 27 | 430 | Terns Pharmaceuticals Inc | Stock-Other | 0.59% | — | -42.34% | |
| 28 | NEXT | Nextdecade CORP | Stock-Other | 0.16% | -0.07% | — | |
| 29 | SRZNW | Surrozen Inc-cw25 | Stock-Other | — | -0.01% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | WYNN | Wynn Resorts LTD | +4.8% | NEW | New buy |
| 2 | GDX | Vaneck Gold Miners ETF | +3.9% | NEW | New buy |
| 3 | BMY | Bristol-myers Squibb Co | +3.8% | NEW | New buy |
| 4 | OSCR | Oscar Health Inc - Class A | +3.6% | +332.39% | Add |
| 5 | IBIT | Ishares Bitcoin Trust ETF | +2% | NEW | New buy |
| 6 | BLCO | Bausch + Lomb CORP | +1.1% | — | Unchanged |
| 7 | EWTX | Edgewise Therapeutics Inc | +1% | NEW | New buy |
| 8 | SVRA | Savara Inc | +0.8% | NEW | New buy |
| 9 | TEVA | Teva Pharmaceutical-sp Adr | +0.6% | — | Unchanged |
| 10 | ALNY | Alnylam Pharmaceuticals Inc | +0.5% | — | Unchanged |
| 11 | MS | Morgan Stanley | +0.4% | — | Unchanged |
| 12 | GERN | Geron CORP | +0.1% | — | Unchanged |
| 13 | UBER | Uber Technologies Inc | +0.1% | — | Unchanged |
| 14 | CZR | Caesars Entertainment Inc | +0.1% | — | Unchanged |
| 15 | MLCO | Melco Resorts & Entert-adr | +0.1% | — | Unchanged |
| 16 | TOST | Toast Inc-class A | +0.1% | — | Unchanged |
| 17 | PFE | Pfizer Inc | 0% | — | Unchanged |
| 18 | SRZNW | Surrozen Inc-cw25 | — | — | Unchanged |
| 19 | AMZN | Amazon.com Inc | 0% | — | Unchanged |
| 20 | QTRX | Quanterix CORP | -0.1% | — | Unchanged |
| 21 | MSFT | Microsoft CORP | -0.1% | — | Unchanged |
| 22 | XENE | Xenon Pharmaceuticals Inc | -0.1% | — | Unchanged |
| 23 | NEXT | Nextdecade CORP | -0.1% | — | Unchanged |
| 24 | GOOGL | Alphabet Inc-cl A | -0.2% | — | Unchanged |
| 25 | 430 | Terns Pharmaceuticals Inc | -0.3% | -42.34% | Trim |
| 26 | VRTX | Vertex Pharmaceuticals Inc | -0.4% | — | Unchanged |
| 27 | SWTXUSD | Springworks Therapeutics Inc | -0.5% | — | Unchanged |
| 28 | CPRX | Catalyst Pharmaceuticals Inc | -0.6% | -50.87% | Trim |
| 29 | QURE | uniQure N.V. | -0.8% | EXIT | Sold out |
| 30 | BBWI | Bath & Body Works Inc | -0.9% | — | Unchanged |
| 31 | ✓ | Hillevax Inc | -1% | EXIT | Sold out |
| 32 | DXCM | Dexcom Inc | -1.7% | EXIT | Sold out |
| 33 | TSM | Taiwan Semiconductor-sp Adr | -4.6% | EXIT | Sold out |
| 34 | LLY | Eli Lilly & Co | -11.5% | EXIT | Sold out |
According to official SEC Form 13F filings, Bridger Management, LLC reported a total U.S. public equity portfolio value of $150.1M across 29 disclosed positions in Q3 2024.
During Q3 2024, Bridger Management, LLC's top holdings by market value included UBER (11.3%)、MS (9.8%)、VRTX (9.6%). The largest single position, UBER, represented 11.3% of total portfolio value.
In Q3 2024, Bridger Management, LLC made 14 total portfolio adjustments, initiating 6 new buys, adding to 1 positions, trimming 2 holdings, and fully liquidating 5 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.